BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12043230)

  • 1. [Serum level of secretory phospholipase A2 (sPLA2) as a predictor of restenosis after coronary angioplasty].
    Korotaeva AA; Provatorov SI; Samoĭlova EV; Kaminnyĭ AI; Sumarokov AB; Pirkova AA; Samko AN; Prokazova NV
    Ter Arkh; 2002; 74(4):12-5. PubMed ID: 12043230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL.
    Korotaeva AA; Samoilova EV; Kaminny AI; Pirkova AA; Resink TJ; Erne P; Prokazova NV; Tkachuk VA; Chazov EI
    Mol Cell Biochem; 2005 Feb; 270(1-2):107-13. PubMed ID: 15792359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Elevated serum secretory type II phospholipase A2 in patients with coronary heart disease].
    Yu L; Jiang WB; Fu GS; Qin GM; Wang JH; Huang ZQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):812-5. PubMed ID: 17217690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris.
    Kugiyama K; Ota Y; Sugiyama S; Kawano H; Doi H; Soejima H; Miyamoto S; Ogawa H; Takazoe K; Yasue H
    Am J Cardiol; 2000 Oct; 86(7):718-22. PubMed ID: 11018189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.
    Mallat Z; Steg PG; Benessiano J; Tanguy ML; Fox KA; Collet JP; Dabbous OH; Henry P; Carruthers KF; Dauphin A; Arguelles CS; Masliah J; Hugel B; Montalescot G; Freyssinet JM; Asselain B; Tedgui A
    J Am Coll Cardiol; 2005 Oct; 46(7):1249-57. PubMed ID: 16198839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.
    L'Allier PL; Tardif JC; Grégoire J; Joyal M; Lespérance J; Fortier A; Guertin MC
    Can J Cardiol; 2005 May; 21(6):495-500. PubMed ID: 15917878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid peroxidation may predict restenosis after coronary balloon angioplasty.
    Imai K; Matsubara T; Kanashiro M; Ichimiya S; Hotta N
    Jpn Circ J; 2001 Jun; 65(6):495-9. PubMed ID: 11407729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study.
    Mallat Z; Benessiano J; Simon T; Ederhy S; Sebella-Arguelles C; Cohen A; Huart V; Wareham NJ; Luben R; Khaw KT; Tedgui A; Boekholdt SM
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1177-83. PubMed ID: 17303774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up.
    Hartford M; Wiklund O; Mattsson Hultén L; Perers E; Person A; Herlitz J; Hurt-Camejo E; Karlsson T; Caidahl K
    Int J Cardiol; 2006 Mar; 108(1):55-62. PubMed ID: 16516698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina.
    Segev A; Strauss BH; Witztum JL; Lau HK; Tsimikas S
    Am Heart J; 2005 Nov; 150(5):1007-14. PubMed ID: 16290986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-angioplasty of in-stent restenosis versus balloon restenoses--a matched pair comparison.
    Wöhrle J; Kochs M; Vollmer C; Kestler HA; Hombach V; Höher M
    Int J Cardiol; 2004 Feb; 93(2-3):257-62. PubMed ID: 14975556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
    Boekholdt SM; Keller TT; Wareham NJ; Luben R; Bingham SA; Day NE; Sandhu MS; Jukema JW; Kastelein JJ; Hack CE; Khaw KT
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):839-46. PubMed ID: 15692105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.
    Saleh N; Tornvall P
    Atherosclerosis; 2007 Dec; 195(2):374-8. PubMed ID: 17126343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty.
    Schnyder G; Roffi M; Flammer Y; Pin R; Hess OM
    Eur Heart J; 2002 May; 23(9):726-33. PubMed ID: 11977999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of sPLA2 and endothelial function: a substudy of the SPIDER-PCI trial.
    Lavi S; Thorpe K; Luca MC; Liuni A; Floras J; Horlick EM; Ing D; Osten MD; Overgaard CB; Lan J; Parker JD; Cantor WJ; Džavík V
    Can J Cardiol; 2012; 28(2):215-21. PubMed ID: 22281412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory phospholipase A2 in patients with infected pancreatic necroses in acute pancreatitis.
    Mayer J; Rau B; Grewe M; Schoenberg MH; Nevalainen TJ; Beger HG
    Pancreas; 1998 Oct; 17(3):272-7. PubMed ID: 9788541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients.
    Lin MK; Farewell V; Vadas P; Bookman AA; Keystone EC; Pruzanski W
    J Rheumatol; 1996 Jul; 23(7):1162-6. PubMed ID: 8823686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long term outcome in patients with and without restenosis after coronary angioplasty].
    Przewłocki T; Ryniewicz W; Sokołowski A; Pieniazek P; Olszowska M; Kostkiewicz M; Lelakowski J; Tracz W
    Przegl Lek; 2001; 58(9):845-50. PubMed ID: 11868245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary 166Holmium brachytherapy combined with cutting balloon angioplasty for the treatment of in-stent restenosis.
    Park S; Kang WC; Rhee JH; Ko YG; Choi D; Jang Y; Lee JD; Shim WH; Cho SY
    Cardiovasc Radiat Med; 2003; 4(3):119-25. PubMed ID: 14984711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
    Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.